Harvard Medical School

arlo-cel-shows-promise-in-treating-relapsed-myeloma-patients

Arlo-cel Shows Promise in Treating Relapsed Myeloma Patients

Editorial 22 October, 2025

The novel GPRC5D-targeted CAR T-cell therapy, known as arlocabtagene autoleucel (arlo-cel), has demonstrated significant...

surge-in-male-body-dysmorphic-disorder-calls-for-urgent-attention

Surge in Male Body Dysmorphic Disorder Calls for Urgent Attention

Editorial 22 October, 2025

URGENT UPDATE: A rising trend in male body dysmorphic disorder (BDD) is demanding immediate...